Humanized Antibody Market Opportunities 2031
A humanized antibody is obtained from non-human species, and its protein sequences are modified to increase the similarity as it is produced naturally in humans. The process of "humanization" is generally useful to monoclonal antibodies used for human administration as a drug to treat chronic diseases such as cancer.
MARKET DYNAMICS
The humanized antibody market growth is estimated to grow due to increasing incidences of chronic diseases, growing developments in biotechnology sectors, and rising investments by market players operating the biotechnology sector. The market is expected to have growth opportunities due to the biotechnology industry's developments in the Asia Pacific, Middle East, Africa, and South and Central American regions.
MARKET SCOPE
The "Humanized Antibody Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of humanized antibody market with detailed market segmentation by technology, and application. The humanized antibody market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in humanized antibody market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The humanized antibody market is segmented on the basis of, technology, and application. Based on technology, the market is classified as phage display technology, transchromosome mice technology, and CDR-grafting. Based on application, the market is segmented as cancer, autoimmune and genetic diseases, asthma, cardiovascular and hematologic diseases, macular degeneration, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the humanized antibody market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The humanized antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting humanized antibody market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the humanized antibody market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the humanized antibody market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The humanized antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting humanized antibody market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the humanized antibody market in these regions.
MARKET PLAYERS
The report covers key developments in the humanized antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from humanized antibody market are anticipated to have lucrative growth opportunities in the future with the rising demand for humanized antibody market in the global market. Below mentioned is the list of few companies engaged in the humanized antibody market.
The report also includes the profiles of key players in humanized antibody market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott
- Johnson and Johnson Services, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Genentech Inc.
- Biogen Inc.
- GlaxoSmithKline plc
- Wyeth, LLC
- AstraZeneca
- Boehringer Ingelheim International GmbH
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Humanized Antibody Market - By Technology
1.3.2 Humanized Antibody Market - By Application
1.3.3 Humanized Antibody Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMANIZED ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMANIZED ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMANIZED ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMANIZED ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. HUMANIZED ANTIBODY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMANIZED ANTIBODY MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PHAGE DISPLAY TECHNOLOGY
7.3.1. Overview
7.3.2. Phage Display Technology Market Forecast and Analysis
7.4. TRANSCHROMOSOME MICE TECHNOLOGY
7.4.1. Overview
7.4.2. Transchromosome Mice Technology Market Forecast and Analysis
7.5. CDR-GRAFTING
7.5.1. Overview
7.5.2. CDR-grafting Market Forecast and Analysis
8. HUMANIZED ANTIBODY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. AUTOIMMUNE AND GENETIC DISEASES
8.4.1. Overview
8.4.2. Autoimmune and Genetic Diseases Market Forecast and Analysis
8.5. ASTHMA
8.5.1. Overview
8.5.2. Asthma Market Forecast and Analysis
8.6. CARDIOVASCULAR AND HEMATOLOGIC DISEASES
8.6.1. Overview
8.6.2. Cardiovascular and Hematologic Diseases Market Forecast and Analysis
8.7. MACULAR DEGENERATION
8.7.1. Overview
8.7.2. Macular Degeneration Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. HUMANIZED ANTIBODY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Humanized Antibody Market Overview
9.1.2 North America Humanized Antibody Market Forecasts and Analysis
9.1.3 North America Humanized Antibody Market Forecasts and Analysis - By Technology
9.1.4 North America Humanized Antibody Market Forecasts and Analysis - By Application
9.1.5 North America Humanized Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States Humanized Antibody Market
9.1.5.1.1 United States Humanized Antibody Market by Technology
9.1.5.1.2 United States Humanized Antibody Market by Application
9.1.5.2 Canada Humanized Antibody Market
9.1.5.2.1 Canada Humanized Antibody Market by Technology
9.1.5.2.2 Canada Humanized Antibody Market by Application
9.1.5.3 Mexico Humanized Antibody Market
9.1.5.3.1 Mexico Humanized Antibody Market by Technology
9.1.5.3.2 Mexico Humanized Antibody Market by Application
9.2. EUROPE
9.2.1 Europe Humanized Antibody Market Overview
9.2.2 Europe Humanized Antibody Market Forecasts and Analysis
9.2.3 Europe Humanized Antibody Market Forecasts and Analysis - By Technology
9.2.4 Europe Humanized Antibody Market Forecasts and Analysis - By Application
9.2.5 Europe Humanized Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Humanized Antibody Market
9.2.5.1.1 Germany Humanized Antibody Market by Technology
9.2.5.1.2 Germany Humanized Antibody Market by Application
9.2.5.2 France Humanized Antibody Market
9.2.5.2.1 France Humanized Antibody Market by Technology
9.2.5.2.2 France Humanized Antibody Market by Application
9.2.5.3 Italy Humanized Antibody Market
9.2.5.3.1 Italy Humanized Antibody Market by Technology
9.2.5.3.2 Italy Humanized Antibody Market by Application
9.2.5.4 Spain Humanized Antibody Market
9.2.5.4.1 Spain Humanized Antibody Market by Technology
9.2.5.4.2 Spain Humanized Antibody Market by Application
9.2.5.5 United Kingdom Humanized Antibody Market
9.2.5.5.1 United Kingdom Humanized Antibody Market by Technology
9.2.5.5.2 United Kingdom Humanized Antibody Market by Application
9.2.5.6 Rest of Europe Humanized Antibody Market
9.2.5.6.1 Rest of Europe Humanized Antibody Market by Technology
9.2.5.6.2 Rest of Europe Humanized Antibody Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Humanized Antibody Market Overview
9.3.2 Asia-Pacific Humanized Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Humanized Antibody Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Humanized Antibody Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Humanized Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Humanized Antibody Market
9.3.5.1.1 Australia Humanized Antibody Market by Technology
9.3.5.1.2 Australia Humanized Antibody Market by Application
9.3.5.2 China Humanized Antibody Market
9.3.5.2.1 China Humanized Antibody Market by Technology
9.3.5.2.2 China Humanized Antibody Market by Application
9.3.5.3 India Humanized Antibody Market
9.3.5.3.1 India Humanized Antibody Market by Technology
9.3.5.3.2 India Humanized Antibody Market by Application
9.3.5.4 Japan Humanized Antibody Market
9.3.5.4.1 Japan Humanized Antibody Market by Technology
9.3.5.4.2 Japan Humanized Antibody Market by Application
9.3.5.5 South Korea Humanized Antibody Market
9.3.5.5.1 South Korea Humanized Antibody Market by Technology
9.3.5.5.2 South Korea Humanized Antibody Market by Application
9.3.5.6 Rest of Asia-Pacific Humanized Antibody Market
9.3.5.6.1 Rest of Asia-Pacific Humanized Antibody Market by Technology
9.3.5.6.2 Rest of Asia-Pacific Humanized Antibody Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Humanized Antibody Market Overview
9.4.2 Middle East and Africa Humanized Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Humanized Antibody Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Humanized Antibody Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Humanized Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Humanized Antibody Market
9.4.5.1.1 South Africa Humanized Antibody Market by Technology
9.4.5.1.2 South Africa Humanized Antibody Market by Application
9.4.5.2 Saudi Arabia Humanized Antibody Market
9.4.5.2.1 Saudi Arabia Humanized Antibody Market by Technology
9.4.5.2.2 Saudi Arabia Humanized Antibody Market by Application
9.4.5.3 U.A.E Humanized Antibody Market
9.4.5.3.1 U.A.E Humanized Antibody Market by Technology
9.4.5.3.2 U.A.E Humanized Antibody Market by Application
9.4.5.4 Rest of Middle East and Africa Humanized Antibody Market
9.4.5.4.1 Rest of Middle East and Africa Humanized Antibody Market by Technology
9.4.5.4.2 Rest of Middle East and Africa Humanized Antibody Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Humanized Antibody Market Overview
9.5.2 South and Central America Humanized Antibody Market Forecasts and Analysis
9.5.3 South and Central America Humanized Antibody Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Humanized Antibody Market Forecasts and Analysis - By Application
9.5.5 South and Central America Humanized Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Humanized Antibody Market
9.5.5.1.1 Brazil Humanized Antibody Market by Technology
9.5.5.1.2 Brazil Humanized Antibody Market by Application
9.5.5.2 Rest of South and Central America Humanized Antibody Market
9.5.5.2.1 Rest of South and Central America Humanized Antibody Market by Technology
9.5.5.2.2 Rest of South and Central America Humanized Antibody Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMANIZED ANTIBODY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMANIZED ANTIBODY MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON AND JOHNSON SERVICES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GENENTECH INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOGEN INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. WYETH, LLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASTRAZENECA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abbott
2. Johnson and Johnson Services, Inc.
3. Novartis AG
4. F. Hoffmann-La Roche Ltd
5. Genentech Inc.
6. Biogen Inc.
7. GlaxoSmithKline plc
8. Wyeth, LLC
9. AstraZeneca
10. Boehringer Ingelheim International GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For